Fierce Pharma Feature: Small molecule biomarkers in precision medicine
Por um escritor misterioso
Descrição
This contributed piece to Fierce Pharma discusses small molecule biomarkers & how next-gen mass spectrometry is enabling their discovery on an entirely new scale.
Overview Archives - Sapient, Discovery Metabolomics Lab, Small Molecule Biomarkers - Sapient
Precision medicine in 2020: what barriers remain for drug developers?
Integration of personalized drug delivery systems into digital health - ScienceDirect
The road to precision medicine: Eliminating the “One Size Fits All” approach in Alzheimer's disease - ScienceDirect
Fierce Biotech's 2022 Fierce 15
Fierce Biotech's 2022 Fierce 15
Fierce Pharma Feature: Small molecule biomarkers in precision medicine
Vincent Ling on LinkedIn: Interesting article on the costs of developing precision / personalized…
Frontiers Precision Medicine and the Role of Biomarkers of Radiotherapy Response in Breast Cancer
2023's Fiercest Women in Life Sciences
Alto Neuroscience uses AI to create biomarkers for mental health drugs
Techniques and Strategies for Potential Protein Target Discovery and Active Pharmaceutical Molecule Screening in a Pandemic
A call to action: molecular pathology in Brazil, Surgical and Experimental Pathology
AI Enabled Precision Medicine: Patient Stratification, Drug Repurposing and Combination Therapies
/i.s3.glbimg.com/v1/AUTH_59edd422c0c84a879bd37670ae4f538a/internal_photos/bs/2023/f/5/7aCfv5SMO0Tdyz2MNkTQ/eb51e710-d457-11ed-8a97-6fc889d92f94.jpg)